Back
Lvmh Moet Hennessy Louis Vuitton SE Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
53
LVMHF
Lvmh Moet Hennessy Louis Vuitton SE
Last Price:
$737.00
Seasonality Move:
5.18%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
$105.29
Seasonality Move:
1.75%
Buy
53
Lvmh Moet Hennessy Louis Vuitton SE (LVMHF)
is a Buy
Is Lvmh Moet Hennessy Louis Vuitton SE a Buy, Sell or Hold?
-
The current Lvmh Moet Hennessy Louis Vuitton SE [LVMHF] share price is $744.40. The Score for LVMHF is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
LVMHF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LVMHF Stock Price Chart
What is Lvmh Moet Hennessy Louis Vuitton SE's stock price today?
-
The Lvmh Moet Hennessy Louis Vuitton SE share price today is $744.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LVMHF is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $107.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
LVMHF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.73 | Buy |
Relative Strength Index (14 RSI): | 59.19 | Buy |
Chaikin Money Flow: | -379 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (688.28 - 755.18) | Buy |
Bollinger Bands (100): | (635.75 - 725.21) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 33.84 | Sell |
Chaikin Money Flow: | -502758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.52 - 119.16) | Sell |
Bollinger Bands (100): | (114.38 - 127.78) | Sell |
LVMHF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 721.33 | Buy |
20-day SMA: | 733.94 | Buy |
50-day SMA: | 690.38 | Buy |
200-day SMA: | 721.23 | Buy |
8-day EMA: | 728.41 | Buy |
20-day EMA: | 720.69 | Buy |
50-day EMA: | 700.34 | Buy |
200-day EMA: | 719.54 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.57 | Sell |
20-day SMA: | 114.25 | Sell |
50-day SMA: | 119.8 | Sell |
200-day SMA: | 128.55 | Sell |
8-day EMA: | 110.88 | Sell |
20-day EMA: | 113.91 | Sell |
50-day EMA: | 117.81 | Sell |
200-day EMA: | 123.39 | Sell |
Lvmh Moet Hennessy Louis Vuitton SE Earnings Growth & LVMHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Lvmh Moet Hennessy Louis Vuitton SE Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |